<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d341">
    <sentence id="DDI-DrugBank.d341.s0" text="Specific drug interaction studies have not been conducted with ENBREL .">
        <entity id="DDI-DrugBank.d341.s0.e0" charOffset="63-68"
            type="brand" text="ENBREL"/>
    </sentence>
    <sentence id="DDI-DrugBank.d341.s1" text="However, it was observed that the pharmacokinetics of ENBREL  was unaltered by concomitant methotrexate in rheumatoid arthritis patients.">
        <entity id="DDI-DrugBank.d341.s1.e0" charOffset="54-59"
            type="brand" text="ENBREL"/>
        <entity id="DDI-DrugBank.d341.s1.e1" charOffset="91-102"
            type="drug" text="methotrexate"/>
        <pair id="DDI-DrugBank.d341.s1.p0" e1="DDI-DrugBank.d341.s1.e0"
            e2="DDI-DrugBank.d341.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d341.s2" text="In a study in which patients with active RA were treated for up to 24 weeks with concurrent ENBREL  and anakinra therapy, a 7% rate of serious infections was observed, which was higher than that observed with ENBREL  alone (0%).">
        <entity id="DDI-DrugBank.d341.s2.e0" charOffset="92-97"
            type="brand" text="ENBREL"/>
        <entity id="DDI-DrugBank.d341.s2.e1" charOffset="104-111"
            type="drug" text="anakinra"/>
        <entity id="DDI-DrugBank.d341.s2.e2" charOffset="209-214"
            type="brand" text="ENBREL"/>
        <pair id="DDI-DrugBank.d341.s2.p0" e1="DDI-DrugBank.d341.s2.e0"
            e2="DDI-DrugBank.d341.s2.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d341.s2.p1" e1="DDI-DrugBank.d341.s2.e0"
            e2="DDI-DrugBank.d341.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d341.s2.p2" e1="DDI-DrugBank.d341.s2.e1"
            e2="DDI-DrugBank.d341.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d341.s3" text="Two percent of patients treated concurrently with ENBREL  and anakinra developed neutropenia (ANC   1 x 109/L).">
        <entity id="DDI-DrugBank.d341.s3.e0" charOffset="50-55"
            type="brand" text="ENBREL"/>
        <entity id="DDI-DrugBank.d341.s3.e1" charOffset="62-69"
            type="drug" text="anakinra"/>
        <pair id="DDI-DrugBank.d341.s3.p0" e1="DDI-DrugBank.d341.s3.e0"
            e2="DDI-DrugBank.d341.s3.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d341.s4" text="Patients in a clinical study who were on established therapy with sulfasalazine, to which ENBREL was added, were noted to develop a mild decrease in mean neutrophil counts in comparison to groups treated with either ENBREL CI or sulfasalazine alone.">
        <entity id="DDI-DrugBank.d341.s4.e0" charOffset="66-78"
            type="drug" text="sulfasalazine"/>
        <entity id="DDI-DrugBank.d341.s4.e1" charOffset="90-95"
            type="brand" text="ENBREL"/>
        <entity id="DDI-DrugBank.d341.s4.e2" charOffset="216-221"
            type="brand" text="ENBREL"/>
        <entity id="DDI-DrugBank.d341.s4.e3" charOffset="229-241"
            type="drug" text="sulfasalazine"/>
        <pair id="DDI-DrugBank.d341.s4.p0" e1="DDI-DrugBank.d341.s4.e0"
            e2="DDI-DrugBank.d341.s4.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d341.s4.p1" e1="DDI-DrugBank.d341.s4.e0"
            e2="DDI-DrugBank.d341.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d341.s4.p2" e1="DDI-DrugBank.d341.s4.e0"
            e2="DDI-DrugBank.d341.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d341.s4.p3" e1="DDI-DrugBank.d341.s4.e1"
            e2="DDI-DrugBank.d341.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d341.s4.p4" e1="DDI-DrugBank.d341.s4.e1"
            e2="DDI-DrugBank.d341.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d341.s4.p5" e1="DDI-DrugBank.d341.s4.e2"
            e2="DDI-DrugBank.d341.s4.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d341.s5" text="The clinical significance of this observation is unknown."/>
</document>
